OPRX
OptimizeRx Corporation
Price Chart
Latest Quote
$4.68
-0.30 (-6.02%)
Current Price
| Previous Close | $4.98 |
| Open | $4.93 |
| Day High | $5.00 |
| Day Low | $4.66 |
| Volume | 404,914 |
Stock Information
| Shares Outstanding | 18.77M |
| Total Debt | $23.72M |
| Cash Equivalents | $20.17M |
| Revenue | $107.34M |
| Net Income | $6.84M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $87.82M |
| P/E Ratio | 13.00 |
| EPS (TTM) | $0.36 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $91.37M |
| Sales | $107.34M |
| Income | $6.84M |
| Book/sh | $6.84 |
| Cash/sh | $1.07 |
| Employees | 132 |
Financial Ratios
| Quick Ratio | 5.07 |
| Current Ratio | 5.37 |
| Debt/Eq | 18.30 |
Returns & Margins
| ROA | 5.43% |
| ROE | 5.56% |
| Gross Margin | 70.04% |
| Operating Margin | 2.00% |
| Profit Margin | 6.37% |
Ownership
| Insider Ownership | 12.88% |
| Institutional Ownership | 77.72% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 4.30 |
| PEG | 1.61 |
| P/S | 0.82 |
| P/B | 0.68 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $11.50 |
Technical Indicators
| SMA20 | $5.10 |
| SMA50 | $5.73 |
| SMA200 | $11.45 |
| RSI | 34.09 |
| ATR | 0.3057 |
| Shares Float | 14.43M |
| Short Float | 9.67% |
| Short Ratio | 3.26 |
| Volatility | 1.10 |
| Rel Volume | 1.30 |
Performance History
| Week | -10.52% |
| Month | -5.84% |
| Quarter | -21.87% |
| 6 Months | -64.30% |
| YTD | -62.32% |
| Year | -64.25% |
| 3 Years | -68.82% |
| 5 Years | -90.68% |
| 10 Years | +35.65% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $4.68 | 426,100 |
| 2026-06-18 | $4.98 | 557,300 |
| 2026-06-17 | $5.08 | 367,800 |
| 2026-06-16 | $5.28 | 171,800 |
| 2026-06-15 | $5.32 | 198,200 |
| 2026-06-12 | $5.23 | 151,800 |
| 2026-06-11 | $5.28 | 289,900 |
| 2026-06-10 | $5.08 | 299,900 |
| 2026-06-09 | $5.07 | 307,000 |
| 2026-06-08 | $5.05 | 222,900 |
| 2026-06-05 | $5.11 | 226,100 |
| 2026-06-04 | $5.38 | 475,900 |
| 2026-06-03 | $4.95 | 330,800 |
| 2026-06-02 | $5.28 | 341,700 |
| 2026-06-01 | $5.38 | 408,800 |
| 2026-05-29 | $5.19 | 528,600 |
| 2026-05-28 | $5.10 | 248,300 |
| 2026-05-27 | $4.88 | 391,600 |
| 2026-05-26 | $4.83 | 291,200 |
About OptimizeRx Corporation
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
đ° Latest News
OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations
Simply Wall St. âĸ 2026-06-17T23:22:38Z
OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust
GuruFocus.com âĸ 2026-06-09T12:33:15ZOptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
Zacks âĸ 2026-05-28T15:02:00Z
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
Zacks âĸ 2026-05-20T14:40:00Z
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
Zacks âĸ 2026-05-20T12:46:00Z
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
Zacks âĸ 2026-05-15T14:09:00Z
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates
Simply Wall St. âĸ 2026-05-15T11:41:28Z
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-14T19:24:42Z
OptimizeRx Corp (OPRX) Q1 2026 Earnings Call Highlights: Strong AI Growth Amid Revenue Challenges
GuruFocus.com âĸ 2026-05-13T05:02:37ZOptimizeRx Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T02:06:18Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $35,834,000 | $32,749,000 | $28,622,000 | $23,483,336 |
| Cost Of Revenue | $35,834,000 | $32,749,000 | $28,622,000 | $23,483,336 |
| Total Revenue | $109,429,000 | $92,127,000 | $71,522,000 | $62,450,156 |
| Operating Revenue | $109,429,000 | $92,127,000 | $71,522,000 | $62,450,156 |
| Expenses | ||||
| Interest Expense | $5,294,000 | $6,160,000 | $1,454,000 | $0 |
| Total Expenses | $97,368,000 | $98,344,000 | $89,044,000 | $74,740,894 |
| Other Income Expense | $-170,000 | $-7,337,000 | $-8,380,000 | - |
| Other Non Operating Income Expenses | $198,000 | $152,000 | $500,000 | - |
| Net Non Operating Interest Income Expense | $-4,941,000 | $-5,831,000 | $738,000 | $852,298 |
| Interest Expense Non Operating | $5,294,000 | $6,160,000 | $1,454,000 | $0 |
| Operating Expense | $61,534,000 | $65,595,000 | $60,422,000 | $51,257,558 |
| General And Administrative Expense | $57,207,000 | $61,266,000 | $58,020,000 | $49,235,529 |
| Other Operating Expenses | - | - | - | - |
| Selling And Marketing Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Net Interest Income | $-4,941,000 | $-5,831,000 | $738,000 | $852,298 |
| Interest Income | $353,000 | $329,000 | $2,192,000 | $852,298 |
| Normalized Income | $5,403,584 | $-14,193,690 | $-11,367,221 | $-11,438,440 |
| Net Income From Continuing And Discontinued Operation | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Total Operating Income As Reported | $11,693,000 | $-13,706,000 | $-26,402,000 | $-12,290,738 |
| Average Dilution Earnings | $0 | $0 | $0 | $0 |
| Net Income Common Stockholders | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Net Income | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Net Income Including Noncontrolling Interests | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Net Income Continuous Operations | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Pretax Income | $6,950,000 | $-19,385,000 | $-25,164,000 | $-11,438,440 |
| Special Income Charges | $-368,000 | $-7,489,000 | $-8,880,000 | $0 |
| Interest Income Non Operating | $353,000 | $329,000 | $2,192,000 | $852,298 |
| Operating Income | $12,061,000 | $-6,217,000 | $-17,522,000 | $-12,290,738 |
| Depreciation Amortization Depletion Income Statement | $4,327,000 | $4,329,000 | $2,402,000 | $2,022,029 |
| Depreciation And Amortization In Income Statement | $4,327,000 | $4,329,000 | $2,402,000 | $2,022,029 |
| Gross Profit | $73,595,000 | $59,378,000 | $42,900,000 | $38,966,820 |
| Per Share | ||||
| Diluted EPS | $0.27 | $-1.10 | $-1.03 | $-0.64 |
| Basic EPS | $0.28 | $-1.10 | $-1.03 | $-0.64 |
| Other | ||||
| Tax Effect Of Unusual Items | $-96,416 | $-1,572,690 | $-2,681,221 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $16,939,000 | $-1,407,000 | $-12,428,000 | $-9,416,411 |
| Total Unusual Items | $-368,000 | $-7,489,000 | $-8,880,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-368,000 | $-7,489,000 | $-8,880,000 | $0 |
| Reconciled Depreciation | $4,327,000 | $4,329,000 | $2,402,000 | $2,022,029 |
| EBITDA (Bullshit earnings) | $16,571,000 | $-8,896,000 | $-21,308,000 | $-9,416,411 |
| EBIT | $12,244,000 | $-13,225,000 | $-23,710,000 | $-11,438,440 |
| Diluted Average Shares | $18,998,463 | $18,292,935 | $17,124,801 | $17,783,992 |
| Basic Average Shares | $18,555,343 | $18,292,935 | $17,124,801 | $17,783,992 |
| Diluted NI Availto Com Stockholders | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Tax Provision | $1,818,000 | $725,000 | $-7,598,000 | $0 |
| Impairment Of Capital Assets | $368,000 | $7,489,000 | $6,738,000 | $0 |
| Selling General And Administration | $57,207,000 | $61,266,000 | $58,020,000 | $49,235,529 |
| Other Gand A | $50,245,000 | $49,799,000 | $44,303,000 | $33,489,707 |
| Salaries And Wages | $6,962,000 | $11,467,000 | $13,717,000 | $15,745,822 |
| Gain On Sale Of Business | - | $0 | $-2,142,000 | $0 |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $16,629,000 | $613,000 | $-1,200,000 | $90,414,046 |
| Total Assets | $176,918,000 | $171,168,000 | $183,374,000 | $134,651,185 |
| Total Non Current Assets | $112,203,000 | $117,197,000 | $129,043,000 | $36,074,550 |
| Other Non Current Assets | $28,000 | $296,000 | $568,000 | $5,051 |
| Goodwill And Other Intangible Assets | $111,665,000 | $116,385,000 | $127,753,000 | $35,696,731 |
| Other Intangible Assets | $40,796,000 | $45,516,000 | $49,396,000 | $13,022,911 |
| Current Assets | $64,715,000 | $53,971,000 | $54,331,000 | $98,576,635 |
| Other Current Assets | $512,000 | $248,000 | $405,000 | $473,652 |
| Prepaid Assets | $2,334,000 | $2,131,000 | $2,785,000 | $1,807,176 |
| Receivables | $38,504,000 | $38,212,000 | $37,289,000 | $22,155,301 |
| Taxes Receivable | $752,000 | $0 | $1,036,000 | $0 |
| Accounts Receivable | $37,752,000 | $38,212,000 | $36,253,000 | $22,155,301 |
| Allowance For Doubtful Accounts Receivable | $-260,000 | $-335,000 | $-239,000 | $-352,043 |
| Gross Accounts Receivable | $38,012,000 | $38,547,000 | $36,492,000 | $22,507,344 |
| Cash Cash Equivalents And Short Term Investments | $23,365,000 | $13,380,000 | $13,852,000 | $74,140,506 |
| Cash And Cash Equivalents | $23,365,000 | $13,380,000 | $13,852,000 | $18,208,685 |
| Debt | ||||
| Net Debt | $2,311,000 | $19,436,000 | $22,379,000 | - |
| Total Debt | $26,103,000 | $33,193,000 | $36,824,000 | $234,434 |
| Long Term Debt And Capital Lease Obligation | $21,655,000 | $31,025,000 | $34,602,000 | $144,532 |
| Long Term Debt | $21,421,000 | $30,816,000 | $34,231,000 | - |
| Current Debt And Capital Lease Obligation | $4,448,000 | $2,168,000 | $2,222,000 | $89,902 |
| Current Debt | $4,255,000 | $2,000,000 | $2,000,000 | - |
| Other Current Borrowings | $4,255,000 | $2,000,000 | $2,000,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $48,624,000 | $54,170,000 | $56,821,000 | $8,540,408 |
| Total Non Current Liabilities Net Minority Interest | $27,360,000 | $35,516,000 | $38,939,000 | $144,532 |
| Non Current Deferred Liabilities | $5,705,000 | $4,491,000 | $4,337,000 | $0 |
| Non Current Deferred Taxes Liabilities | $5,705,000 | $4,491,000 | $4,337,000 | $0 |
| Current Liabilities | $21,264,000 | $18,654,000 | $17,882,000 | $8,395,876 |
| Current Deferred Liabilities | $503,000 | $473,000 | $172,000 | $164,309 |
| Payables And Accrued Expenses | $16,313,000 | $16,013,000 | $15,488,000 | $8,141,665 |
| Payables | $4,722,000 | $7,527,000 | $7,782,000 | $5,540,419 |
| Other Payable | $3,086,000 | $5,053,000 | $5,506,000 | $3,990,440 |
| Total Tax Payable | $0 | $318,000 | $49,000 | - |
| Accounts Payable | $1,636,000 | $2,156,000 | $2,227,000 | $1,549,979 |
| Equity | ||||
| Common Stock Equity | $128,294,000 | $116,998,000 | $126,553,000 | $126,110,777 |
| Total Equity Gross Minority Interest | $128,294,000 | $116,998,000 | $126,553,000 | $126,110,777 |
| Stockholders Equity | $128,294,000 | $116,998,000 | $126,553,000 | $126,110,777 |
| Retained Earnings | $-79,236,000 | $-84,368,000 | $-64,258,000 | $-46,692,098 |
| Other | ||||
| Treasury Shares Number | $1,741,397 | $1,741,397 | $1,741,397 | $1,214,398 |
| Preferred Shares Number | $65 | $65 | $65 | $65 |
| Ordinary Shares Number | $18,759,589 | $18,453,300 | $18,158,282 | $17,074,173 |
| Share Issued | $20,500,986 | $20,194,697 | $19,899,679 | $18,288,571 |
| Tangible Book Value | $16,629,000 | $613,000 | $-1,200,000 | $90,414,046 |
| Invested Capital | $153,970,000 | $149,814,000 | $162,784,000 | $126,110,777 |
| Working Capital | $43,451,000 | $35,317,000 | $36,449,000 | $90,180,759 |
| Capital Lease Obligations | $427,000 | $377,000 | $593,000 | $234,434 |
| Total Capitalization | $149,715,000 | $147,814,000 | $160,784,000 | $126,110,777 |
| Treasury Stock | $2,000 | $2,000 | $2,000 | $1,214 |
| Additional Paid In Capital | $207,512,000 | $201,348,000 | $190,793,000 | $172,785,800 |
| Capital Stock | $20,000 | $20,000 | $20,000 | $18,289 |
| Common Stock | $20,000 | $20,000 | $20,000 | $18,289 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $234,000 | $209,000 | $371,000 | $144,532 |
| Current Deferred Revenue | $503,000 | $473,000 | $172,000 | $164,309 |
| Current Capital Lease Obligation | $193,000 | $168,000 | $222,000 | $89,902 |
| Current Accrued Expenses | $11,591,000 | $8,486,000 | $7,706,000 | $2,601,246 |
| Goodwill | $70,869,000 | $70,869,000 | $78,357,000 | $22,673,820 |
| Net PPE | $510,000 | $516,000 | $722,000 | $372,768 |
| Accumulated Depreciation | $-351,000 | $-258,000 | $-151,000 | $-131,519 |
| Gross PPE | $861,000 | $774,000 | $873,000 | $504,287 |
| Other Properties | $404,000 | $366,000 | $573,000 | $235,320 |
| Machinery Furniture Equipment | $457,000 | $408,000 | $300,000 | $268,967 |
| Other Short Term Investments | - | - | $0 | $55,931,821 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $18,715,000 | $4,439,000 | $-8,111,000 | $10,409,513 |
| Operating Activities | ||||
| Operating Cash Flow | $18,715,000 | $4,889,000 | $-7,240,000 | $10,654,078 |
| Cash Flow From Continuing Operating Activities | $18,715,000 | $4,889,000 | $-7,240,000 | $10,654,078 |
| Operating Gains Losses | - | - | $2,142,000 | - |
| Investing Activities | ||||
| Investing Cash Flow | $68,000 | $-450,000 | $-25,337,000 | $-58,176,386 |
| Cash Flow From Continuing Investing Activities | $68,000 | $-450,000 | $-25,337,000 | $-58,176,386 |
| Capital Expenditure Reported | $126,000 | $-338,000 | $-784,000 | $-163,560 |
| Capital Expenditure | - | $-450,000 | $-871,000 | $-244,565 |
| Financing Activities | ||||
| Financing Cash Flow | $-8,798,000 | $-4,911,000 | $28,220,000 | $-18,950,777 |
| Cash Flow From Continuing Financing Activities | $-8,798,000 | $-4,911,000 | $28,220,000 | $-18,950,777 |
| Net Other Financing Charges | $-1,150,000 | $-911,000 | - | - |
| Repurchase Of Capital Stock | - | $0 | $-7,522,000 | $-20,024,258 |
| Net Common Stock Issuance | - | $0 | $-7,522,000 | $-20,024,258 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-8,000,000 | $-4,000,000 | $-1,710,000 | $0 |
| Interest Paid Supplemental Data | $4,184,000 | $6,203,000 | $1,213,000 | $0 |
| Income Tax Paid Supplemental Data | $1,760,000 | $161,000 | $48,000 | $0 |
| End Cash Position | $23,365,000 | $13,380,000 | $13,852,000 | $18,208,685 |
| Beginning Cash Position | $13,380,000 | $13,852,000 | $18,209,000 | $84,681,770 |
| Changes In Cash | $9,985,000 | $-472,000 | $-4,357,000 | $-66,473,085 |
| Proceeds From Stock Option Exercised | $352,000 | $0 | $-278,000 | $1,073,481 |
| Net Issuance Payments Of Debt | $-8,000,000 | $-4,000,000 | $36,020,000 | $0 |
| Net Long Term Debt Issuance | $-8,000,000 | $-4,000,000 | $36,020,000 | $0 |
| Long Term Debt Payments | $-8,000,000 | $-4,000,000 | $-1,710,000 | $0 |
| Net PPE Purchase And Sale | $-58,000 | $-112,000 | $-77,000 | $-81,005 |
| Purchase Of PPE | $-58,000 | $-112,000 | $-87,000 | $-81,005 |
| Change In Working Capital | $816,000 | $671,000 | $-15,550,000 | $3,961,155 |
| Change In Other Working Capital | $-76,000 | $1,500,000 | $-7,762,000 | $-1,225,598 |
| Change In Other Current Liabilities | $12,000 | $0 | - | $226 |
| Change In Payables And Accrued Expense | $887,000 | $528,000 | $1,498,000 | $254,029 |
| Change In Accrued Expense | $3,374,000 | $1,053,000 | $1,303,000 | $-301,366 |
| Change In Payable | $-2,487,000 | $-525,000 | $195,000 | $555,395 |
| Change In Account Payable | $-2,487,000 | $-525,000 | $195,000 | $555,395 |
| Change In Prepaid Assets | $-467,000 | $811,000 | $-573,000 | $2,650,951 |
| Change In Receivables | $460,000 | $-2,168,000 | $-8,713,000 | $2,281,773 |
| Changes In Account Receivables | $460,000 | $-2,168,000 | $-8,713,000 | $2,281,773 |
| Other Non Cash Items | $1,110,000 | $835,000 | $211,000 | - |
| Stock Based Compensation | $6,962,000 | $11,467,000 | $13,717,000 | $15,745,822 |
| Asset Impairment Charge | $368,000 | $7,697,000 | $7,404,000 | $363,512 |
| Depreciation Amortization Depletion | $4,327,000 | $4,329,000 | $2,402,000 | $2,022,029 |
| Depreciation And Amortization | $4,327,000 | $4,329,000 | $2,402,000 | $2,022,029 |
| Amortization Cash Flow | $4,225,000 | $4,218,000 | $2,302,000 | $1,936,304 |
| Amortization Of Intangibles | $4,225,000 | $4,218,000 | $2,302,000 | $1,936,304 |
| Depreciation | $102,000 | $111,000 | $100,000 | $85,725 |
| Net Income From Continuing Operations | $5,132,000 | $-20,110,000 | $-17,566,000 | $-11,438,440 |
| Issuance Of Debt | - | $0 | $37,730,000 | $0 |
| Common Stock Payments | - | $0 | $-7,522,000 | $-20,024,258 |
| Long Term Debt Issuance | - | $0 | $37,730,000 | $0 |
| Net Investment Purchase And Sale | - | $0 | $55,931,000 | $-55,931,821 |
| Sale Of Investment | - | $0 | $218,709,000 | $0 |
| Purchase Of Investment | - | $0 | $-162,778,000 | $-55,931,821 |
| Net Business Purchase And Sale | - | $0 | $-80,407,000 | $-2,000,000 |
| Sale Of Business | - | $0 | $2,540,000 | $0 |
| Purchase Of Business | - | $0 | $-82,947,000 | $-2,000,000 |
| Sale Of PPE | - | $0 | $10,000 | $0 |
| Gain Loss On Sale Of Business | - | $0 | $2,142,000 | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $-1,830 |
| Purchase Of Intangibles | - | - | - | $-1,830 |
| Provisionand Write Offof Assets | - | - | - | $363,512 |
Fetched: 2026-06-19